Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
The Immunological Consequences of Clonal Hematopoiesis in Heart Failure.
Journal: Immunological reviews
Published: September 15, 2025
Hematopoietic loss of Y chromosome activates immune checkpoints and contributes to impaired senescent cell clearance and renal disease.
Journal: Science translational medicine
Published: August 06, 2025
Clonal Hematopoiesis in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Journal: JACC. CardioOncology
Published: March 11, 2025
Experimental TET2 Clonal Hematopoiesis Predisposes to Renal Hypertension Through an Inflammasome-Mediated Mechanism.
Journal: Circulation research
Published: September 05, 2024
Tet2-mediated clonal hematopoiesis modestly improves neurological deficits and is associated with inflammation resolution in the subacute phase of experimental stroke.
Journal: Frontiers in cellular neuroscience
Published: August 28, 2024
How clonal hematopoiesis promotes inflammation at a single-cell level.
Journal: Nature cardiovascular research
Published: August 28, 2024
Disruption of the Uty epigenetic regulator locus in hematopoietic cells phenocopies the profibrotic attributes of Y chromosome loss in heart failure.
Journal: Nature cardiovascular research
Published: August 26, 2024
Regulators of clonal hematopoiesis and physiological consequences of this condition.
Journal: The journal of cardiovascular aging
Published: August 09, 2024
Clonal Hematopoiesis: Getting to the Heart of the Problem With Clone Size.
Journal: JACC. Heart failure
Published: December 19, 2023
Last Updated: 09/26/2026